ANTIBIOTIC RESISTANCE MARKETS - THERAPEUTICS

"ANTIBIOTIC RESISTANCE MARKETS - THERAPEUTICS.  By Pathogen and Therapy Type.  With Situation Analysis, Executive & Investor Guides & Customization.   2022 to 2026"

420 Pages packed with information 

Search for Alternatives to Antibiotics creates new global technology race.  Over 100 companies in the running…

Antimicrobial Resistance is creating new kinds of infections and “superbugs” that are resistant to current antibiotic medicines.  New technologies (and new drugs) are under development to capture this growing market.  We have identified the 6 Key Large Opportunities in this space and developed market forecasts.  We have looked at the technology picture too, giving you, plain language understanding of the different ways pathogens, and infections, can be treated, including an explanation of the key role diagnostics will play.  This is a market with a lot of players, there are over 100 biotechnology companies profiled in the report.  And we summarize what technologies they are using.

Our research makes you the expert in your organization. Get our research team working for you by ordering all, or a portion, of this comprehensive report.  Your credit card order sends the report to your inbox instantly.  Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges. 

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.  

See the Table of Contents.

Send an email to us at service@howesoundresearch.com and we will happily email you a FREE copy of SAMPLE PAGES FROM THIS REPORT without any obligation on your part.  And we will not pester you with phone calls!

Make investment decisions and valuations with confidence using the latest data.  

ABOUT THE LEAD AUTHOR

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research and the American Association for Clinical Chemistry. 

He is an experienced business and clinical professional.  He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping."  He has worked in laboratory testing and management for over 20 years.  Mr. Powell’s education includes:

B.Sc. (Chemistry) University of BC

M.B.A. (Finance and Policy) University of BC

Market Research  - Burke Institute

Finance for Senior Executives - Harvard Business School